Aspirin and Acetaminophen Use and the Risk of Cervical Cancer

Journal of Lower Genital Tract Disease

Volumn 19, Issue 3, 2015, Pages 189-193

  Friel, Grace ^a   Liu, Cici S ^b   Kolomeyevskaya, Nonna V ^a   Hampras, Shalaka S ^c   Kruszka, Bridget ^a   Schmitt, Kristina ^a   Cannioto, Rikki A ^a   Lele, Shashikant B ^a   Odunsi, Kunle O ^a   Moysich, Kirsten B ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

acetaminophen; aspirin; cervical cancer; COX 2; NSAID

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; ANALGESIC AGENT;

ADENOCARCINOMA; ADULT; ARTICLE; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CONTROLLED STUDY; DISTANT METASTASIS; DRUG INDUCED CANCER; DRUG USE; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; REGIONAL METASTASIS; RISK ASSESSMENT; UTERINE CERVIX ADENOCARCINOMA; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; AGED; CANCER CENTER; MIDDLE AGED; NEW YORK; PATHOLOGY; QUESTIONNAIRE; RISK FACTOR; SQUAMOUS CELL CARCINOMA; STATISTICAL MODEL; UTERINE CERVICAL NEOPLASMS;

ACETAMINOPHEN; ADENOCARCINOMA; ADULT; AGED; ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CANCER CARE FACILITIES; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; NEW YORK; RISK FACTORS; SURVEYS AND QUESTIONNAIRES; UTERINE CERVICAL NEOPLASMS;

EID: 84937679437     PISSN: 10892591     EISSN: 15260976     Source Type: Journal    
DOI: 10.1097/LGT.0000000000000104     Document Type: Article

References (31)

1. Boccardo E, Lepique AP, Villa LL. The role of inflammation in HPV carcinogenesis. Carcinogenesis 2010;31:1905-12.
2. Chan AT, Arber N, Burn J, et al. Aspirin in the chemoprevention of colorectal neoplasia: an overview. Cancer Prev Res (Phila, Pa.) 2012;5:164-78.
3. Rothwell PM, Fowkes FG, Belch JF, et al. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 2011;377:31-41.
4. Algra AM, Rothwell PM. Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol 2012;13:518-27.
5. Brasky TM, Bonner MR, Moysich KB, et al. Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study. Cancer Causes Control 2010;21:1503-12.
6. Lo-Ciganic WH, Zgibor JC, Bunker CH, et al. Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, or acetaminophen and risk of ovarian cancer. Epidemiology 2012;23:311-9.
7. Bonovas S, Filioussi K, Sitaras NM. Paracetamol use and risk of ovarian cancer: a meta-analysis. Br J Clin Pharmacol 2006;62:113-21.
8. Baker JA, Weiss JR, Czuczman MS, et al. Regular use of aspirin or acetaminophen and risk of non-Hodgkin lymphoma. Cancer Causes Control 2005;16:301-8.
9. Moysich KB, Bonner MR, Beehler GP, et al. Regular analgesic use and risk of multiple myeloma. Leuk Res 2007;31:547-51.
10. Xiang S, Sun Z, He Q, et al. Aspirin inhibits ErbB2 to induce apoptosis in cervical cancer cells. Med Oncol 2010;27:379-87.
11. Kim KY, Seol JY, Jeon GA, et al. The combined treatment of aspirin and radiation induces apoptosis by the regulation of bcl-2 and caspase-3 in human cervical cancer cell. Cancer Lett 2003;189:157-66.
12. Young JL, Jazaeri AA, Darus CJ, et al. Cyclooxygenase-2 in cervical neoplasia: a review. Gynecol Oncol 2008;109:140-5.
13. Simmons DL, Botting RM, Hla T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 2004;56:387-437.
14. Hinz B, Cheremina O, Brune K. Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man. FASEB J 2008;22:383-90.
15. Kim MH, Seo SS, Song YS, et al. Expression of cyclooxygenase-1 and -2 associated with expression of VEGF in primary cervical cancer and at metastatic lymph nodes. Gynecol Oncol 2003;90:83-90.
16. Jung YW, Kim SW, Kim S, et al. Prevalence and clinical relevance of cyclooxygenase-1 and -2 expression in stage IIB cervical adenocarcinoma. Eur J Obstet Gynecol Reprod Biol 2010;148:62-6.
17. Boulares AH, Ren T. Mechanism of acetaminophen-induced apoptosis in cultured cells: roles of caspase-3, DNA fragmentation factor, and the Ca2+ and Mg2+ endonuclease DNAS1L3. Basic Clin Pharmacol Toxicol 2004;94:19-29.
18. Gates MA, Tworoger SS, Eliassen AH, et al. Analgesic use and sex steroid hormone concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2010;19:1033-41.
19. Au WW, Abdou-Salama S, Al-Hendy A. Inhibition of growth of cervical cancer cells using a dominant negative estrogen receptor gene. Gynecol Oncol 2007;104:276-80.
20. Jaakkola S, Pukkala E, Lyytinen HK, et al. Postmenopausal estradiol-progestagen therapy and risk for uterine cervical cancer. Int J Cancer 2012;131:E537-43.
21. Friis S, Sorensen HT, McLaughlin JK, et al. A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin. Br J Cancer 2003;88:684-8.
22. Sorensen HT, Friis S, Norgard B, et al. Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br J Cancer 2003;88:1687-92.
23. Wilson JC, O'Rorke MA, Cooper JA, et al. Non-steroidal anti-inflammatory drug use and cervical cancer risk: a case-control study using the Clinical Practice Research Datalink. Cancer Epidemiol 2013;37:897-904.
24. 9.3 Procedures Guide. [computer program]. Cary, NC, USA: SAS Institute Inc.; 2011.
25. Rothwell PM, Wilson M, Elwin CE, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 2010;376:1741-50.
26. Wilson JC, O'Rorke MA, Cooper JA, et al. Non-steroidal anti-inflammatory drug use and cervical cancer risk: a case-control study using the Clinical Practice Research Datalink. Cancer Epidemiol 2013;37:897-904.
27. Zhou Y, Boudreau DM, Freedman AN. Trends in the use of aspirin and nonsteroidal anti-inflammatory drugs in the general U.S. population. Pharmacoepidemiol Drug Saf 2014;23:43-50.
28. National Cancer Institute. SEER Cancer Statistics Factsheets: Cervix Uteri Cancer. Bethesda, MD: National Cancer Institute, 2013.
29. Suh O, Mettlin C, Petrelli NJ. Aspirin use, cancer, and polyps of the large bowel. Cancer 1993;72:1171-7.
30. Mettlin C, Croghan I, Natarajan N, et al. The association of age and familial risk in a case-control study of breast cancer. Am J Epidemiol 1990;131:973-83.
31. Harris RE, Beebe-Donk J, Doss H, et al. Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review). Oncol Rep 2005;13:559-83.